| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 53.44B | 53.07B | 48.89B | 49.85B | 45.26B | 41.50B |
| Gross Profit | 11.22B | 10.65B | 8.99B | 8.95B | 6.48B | 5.73B |
| EBITDA | 6.16B | 6.19B | 4.69B | 5.08B | 3.38B | 2.83B |
| Net Income | 2.04B | 2.01B | 1.67B | 1.84B | 90.91M | 670.66M |
Balance Sheet | ||||||
| Total Assets | 80.34B | 80.27B | 77.93B | 70.74B | 69.43B | 68.83B |
| Cash, Cash Equivalents and Short-Term Investments | 12.94B | 13.99B | 12.80B | 12.04B | 11.02B | 9.58B |
| Total Debt | 28.74B | 17.32B | 32.42B | 31.89B | 22.35B | 23.01B |
| Total Liabilities | 45.33B | 46.56B | 48.14B | 46.20B | 46.38B | 46.27B |
| Stockholders Equity | 31.20B | 29.99B | 26.44B | 21.47B | 20.17B | 19.43B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.35B | 461.54M | 836.27M | 3.13B | -1.46B |
| Operating Cash Flow | 0.00 | 6.81B | 4.33B | 4.90B | 4.92B | 3.53B |
| Investing Cash Flow | 0.00 | -1.55B | -3.32B | -3.61B | -1.64B | -5.16B |
| Financing Cash Flow | 0.00 | -4.08B | -135.69M | -321.28M | -1.84B | 2.59B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥5.87B | 5.29 | ― | 3.02% | 7.54% | 44.72% | |
74 Outperform | ¥22.82B | 3.25 | ― | 1.29% | 4.21% | 35.32% | |
72 Outperform | ¥12.31B | 5.41 | ― | 4.99% | 6.11% | 207.55% | |
70 Outperform | ¥21.38B | 15.36 | ― | 1.38% | 7.07% | 26.88% | |
65 Neutral | ¥12.11B | 10.98 | ― | 1.87% | -0.35% | 11.44% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
50 Neutral | ¥6.62B | 19.26 | ― | 0.30% | -0.38% | 413.00% |